Literature DB >> 22992330

Genetic correlate of cognitive training response in schizophrenia.

Rogerio Panizzutti1, Steven P Hamilton, Sophia Vinogradov.   

Abstract

Intensive computerized auditory training results in improved cognition for schizophrenia patients, but participants show variation in their cognitive gains and the biological factors that affect the response to training are unknown. Single nucleotide polymorphisms (SNPs) in the catechol-O-methyltransferase (COMT) gene have been related to cognitive function. Here we asked if functional variation in this gene has an impact on the response of schizophrenia patients to cognitive training. We genotyped 48 schizophrenia patients who completed 50 h of computerized cognitive training and analyzed the association between DNA variants in the COMT gene and the improvement in global cognition. Although conventional analyses did not reveal any significant associations, a set-based analysis examining the aggregate effect of common variation in the COMT gene (42 SNPs) suggested association with improvement in global cognition. Eight SNPs, mostly located in the 3' end of the COMT gene, were nominally associated with improvement in cognition. These data suggest that genotype influences the response to intensive cognitive training in schizophrenia, and may indicate that cognitive training regimens need to be personalized to the underlying biosignatures of each individual patient. This article is part of a Special Issue entitled 'Cognitive Enhancers'. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22992330      PMCID: PMC3448064          DOI: 10.1016/j.neuropharm.2012.07.048

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  13 in total

1.  Set association analysis of SNP case-control and microarray data.

Authors:  Jurg Ott; Josephine Hoh
Journal:  J Comput Biol       Date:  2003       Impact factor: 1.479

2.  The future of association studies: gene-based analysis and replication.

Authors:  Benjamin M Neale; Pak C Sham
Journal:  Am J Hum Genet       Date:  2004-07-22       Impact factor: 11.025

3.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

4.  The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Authors:  Keith H Nuechterlein; Michael F Green; Robert S Kern; Lyle E Baade; Deanna M Barch; Jonathan D Cohen; Susan Essock; Wayne S Fenton; Frederick J Frese; James M Gold; Terry Goldberg; Robert K Heaton; Richard S E Keefe; Helena Kraemer; Raquelle Mesholam-Gately; Larry J Seidman; Ellen Stover; Daniel R Weinberger; Alexander S Young; Steven Zalcman; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

5.  Impact of complex genetic variation in COMT on human brain function.

Authors:  A Meyer-Lindenberg; T Nichols; J H Callicott; J Ding; B Kolachana; J Buckholtz; V S Mattay; M Egan; D R Weinberger
Journal:  Mol Psychiatry       Date:  2006-06-20       Impact factor: 15.992

6.  Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.

Authors:  Marta Bosia; Margherita Bechi; Elena Marino; Simona Anselmetti; Sara Poletti; Federica Cocchi; Enrico Smeraldi; Roberto Cavallaro
Journal:  Neurosci Lett       Date:  2007-03-02       Impact factor: 3.046

7.  Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.

Authors:  Alessandro Bertolino; Grazia Caforio; Giuseppe Blasi; Mariapia De Candia; Valeria Latorre; Vittoria Petruzzella; Mario Altamura; Gaetano Nappi; Sergio Papa; Joseph H Callicott; Venkata S Mattay; Antonello Bellomo; Tommaso Scarabino; Daniel R Weinberger; Marcello Nardini
Journal:  Am J Psychiatry       Date:  2004-10       Impact factor: 18.112

8.  Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.

Authors:  Michael J Minzenberg; John H Poole; Cynthia Benton; Sophia Vinogradov
Journal:  Am J Psychiatry       Date:  2004-01       Impact factor: 18.112

9.  No association between the Catechol-O-Methyltransferase (COMT) val158met polymorphism and cognitive improvement following cognitive remediation therapy (CRT) in schizophrenia.

Authors:  Kathryn Greenwood; Chi-Fa Hung; Maria Tropeano; Peter McGuffin; Til Wykes
Journal:  Neurosci Lett       Date:  2011-03-31       Impact factor: 3.046

10.  Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.

Authors:  Roy H Perlis; Priya Moorjani; Jesen Fagerness; Shaun Purcell; Madhukar H Trivedi; Maurizio Fava; A John Rush; Jordan W Smoller
Journal:  Neuropsychopharmacology       Date:  2008-02-20       Impact factor: 7.853

View more
  12 in total

Review 1.  Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia.

Authors:  Melissa Fisher; Rachel Loewy; Kate Hardy; Danielle Schlosser; Sophia Vinogradov
Journal:  Annu Rev Clin Psychol       Date:  2013-01-07       Impact factor: 18.561

Review 2.  Video games for people with schizophrenia.

Authors:  Matthew T Roberts; Jack Lloyd; Maritta Välimäki; Grace Wk Ho; Megan Freemantle; Anna Zsófia Békefi
Journal:  Cochrane Database Syst Rev       Date:  2021-02-04

Review 3.  Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets.

Authors:  Anthony O Ahmed; Ishrat A Bhat
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

4.  COMT genotype and response to cognitive remediation in schizophrenia.

Authors:  Jean-Pierre Lindenmayer; Anzalee Khan; Herbert Lachman; Susan R McGurk; Abraham Goldring; Amod Thanju; Saurabh Kaushik
Journal:  Schizophr Res       Date:  2015-08-06       Impact factor: 4.939

Review 5.  Cognitive training in mental disorders: update and future directions.

Authors:  Matcheri S Keshavan; Sophia Vinogradov; Judith Rumsey; Joel Sherrill; Ann Wagner
Journal:  Am J Psychiatry       Date:  2014-05       Impact factor: 18.112

6.  Personalised treatment for cognitive dysfunction in individuals with schizophrenia spectrum disorders.

Authors:  Alice Medalia; Alice M Saperstein; Marie C Hansen; Seonjoo Lee
Journal:  Neuropsychol Rehabil       Date:  2016-05-24       Impact factor: 2.868

7.  The Moderating Role of COMT and BDNF Polymorphisms on Transfer Effects Following Multi- and Single-Domain Cognitive Training Among Community-Dwelling Shanghainese Older Adults.

Authors:  Jiangling Jiang; Alexandra J Fiocco; Xinyi Cao; Lijuan Jiang; Wei Feng; Yuan Shen; Ting Li; Chunbo Li
Journal:  Front Aging Neurosci       Date:  2018-07-05       Impact factor: 5.750

Review 8.  Cognitive Deficits in Schizophrenia: Understanding the Biological Correlates and Remediation Strategies.

Authors:  Adarsh Tripathi; Sujita Kumar Kar; Rashmi Shukla
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-02-28       Impact factor: 2.582

Review 9.  Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review.

Authors:  Stefano Barlati; Giacomo Deste; Alessandro Galluzzo; Anna Paola Perin; Paolo Valsecchi; Cesare Turrina; Antonio Vita
Journal:  Front Pharmacol       Date:  2019-01-10       Impact factor: 5.810

Review 10.  A systematic review of moderators of cognitive remediation response for people with schizophrenia.

Authors:  Benedetta Seccomandi; Dimosthenis Tsapekos; Katie Newbery; Til Wykes; Matteo Cella
Journal:  Schizophr Res Cogn       Date:  2019-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.